期刊
CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 89, 期 2, 页码 312-315出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/clpt.2010.291
关键词
-
The current process of benefit-risk assessment of medicines relies primarily on intuitive expert judgment. Frameworks are needed for transparent, rational and defensible decision making that benefits patients, drug developers, and decision makers. The Benefit Risk Action Team framework is a set of processes and tools for selecting, organizing, summarizing, and interpreting data that is relevant to decisions based on benefit-risk assessments. It provides a standardized yet flexible platform for incorporating study outcomes and preference weights as well as for communicating the rationales for decisions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据